{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiguutuvezacg4pw6jw232mqkexg5v74fmhqp7bc4a3yaoc3m2hcru",
    "uri": "at://did:plc:ycan73jxazji4jml4x3432hf/app.bsky.feed.post/3mjynxbbs6op2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid2ug5ignjr35yhutyqefgp4h7i6rsqvhoakcjmhkdx2gygpixa5u"
    },
    "mimeType": "image/png",
    "size": 27223
  },
  "path": "/alex-karnal-glp-1-medicines-could-exceed-100-billion-in-revenue-a-trillion-dollar-public-health-revolution-is-imminent-and-managing-glucose-levels-is-key-to-reducing-cardiovascular-risks-invest/",
  "publishedAt": "2026-04-21T09:12:39.000Z",
  "site": "https://cryptobriefing.com",
  "tags": [
    "Podcast Notes",
    "Invest Like the Best with Patrick O'Shaughnessy",
    "podcast",
    "Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best",
    "Crypto Briefing"
  ],
  "textContent": "GLP-1 medicines are set to revolutionize public health with over $100 billion in annual revenue potential.\n\nThe post Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best appeared first on Crypto Briefing.",
  "title": "Alex Karnal: GLP-1 medicines could exceed $100 billion in revenue, a trillion-dollar public health revolution is imminent, and managing glucose levels is key to reducing cardiovascular risks | Invest Like the Best"
}